Trial Outcomes & Findings for Seroepidemiological Study of Pertussis and Other Infectious Diseases (NCT NCT01929473)
NCT ID: NCT01929473
Last Updated: 2016-07-12
Results Overview
Seroincidence of pertussis estimated by the elevation of Ig-G-PT in paired sera(0day, 365day).
Recruitment status
COMPLETED
Target enrollment
3830 participants
Primary outcome timeframe
0 day, 365 day (2 points)
Results posted on
2016-07-12
Participant Flow
Participant milestones
| Measure |
Blood Drawings (0 Day, 365 Day) and Questionnaires
|
|---|---|
|
Overall Study
STARTED
|
3830
|
|
Overall Study
365 Day
|
3589
|
|
Overall Study
COMPLETED
|
3243
|
|
Overall Study
NOT COMPLETED
|
587
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Seroepidemiological Study of Pertussis and Other Infectious Diseases
Baseline characteristics by cohort
| Measure |
Blood Drawings (0 Day, 365 Day) and Questionnaires
n=3243 Participants
|
|---|---|
|
Age, Continuous
|
13.9 years
STANDARD_DEVIATION 1.56 • n=39 Participants
|
|
Sex: Female, Male
Female
|
1605 Participants
n=39 Participants
|
|
Sex: Female, Male
Male
|
1638 Participants
n=39 Participants
|
|
Region of Enrollment
Japan
|
3243 participants
n=39 Participants
|
PRIMARY outcome
Timeframe: 0 day, 365 day (2 points)Seroincidence of pertussis estimated by the elevation of Ig-G-PT in paired sera(0day, 365day).
Outcome measures
| Measure |
Blood Drawings (0 Day, 365 Day) and Questionnaires
n=3243 Participants
|
|---|---|
|
IgG
0 day
|
1.254 EU/mL(log transformed)
Standard Deviation 0.008
|
|
IgG
365 day
|
1.258 EU/mL(log transformed)
Standard Deviation 0.007
|
SECONDARY outcome
Timeframe: 0 dayQuestionnaire
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 0 dayQuestionnaire
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 365 dayQuestionnaire
Outcome measures
Outcome data not reported
Adverse Events
Blood Drawings (0 Day, 365 Day) and Questionnaires
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place
Restriction type: OTHER